NCT02617537View on ClinicalTrials.gov

To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

October 31, 2017

Conditions

Dysmenorrhea

Interventions

DRUG

EE20/DRSP(YAZ,BAY86-5300)

0.02 mg EE (β-CDC)/3 mg DRSP for 24 days and placebo tablets for 4 days per 28-day intake cycle

DRUG

Placebo

Matching placebo tablets for 28 days per 28-day intake cycle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY